Abstract
Our previous study using RNA sequencing and reverse transcription quantitative polymerase chain reaction (RT-qPCR) validation identified a long non-coding RNA (lnc), lnc-AL928768.3, correlating with risk and disease activity of rheumatoid arthritis (RA), then the present study was conducted to further investigate the interaction of lnc-AL928768.3 with lymphotoxin beta (LTB) and their impact on proliferation, migration, invasion, and inflammation in RA-fibroblast-like synoviocytes (RA-FLS). Human RA-FLS was obtained and transfected with lnc-AL928768.3 overexpression, negative control overexpression, lnc-AL928768.3 short hairpin RNA (shRNA) and negative control shRNA plasmids. Then cell functions and inflammatory cytokine expressions were detected. Afterward, rescue experiments were conducted via transfecting lnc-AL928768.3 shRNA with or without LTB overexpression plasmids in RA-FLS. Lnc-AL928768.3 enhanced proliferation and invasion, inhibited apoptosis, while had little impact on migration in RA-FLS. In addition, lnc-AL928768.3 positively modulated interleukin-1β (IL-1β), IL-6 and IL-8 expressions in RA-FLS supernatant; moreover, it also positively regulated LTB mRNA expression, LTB protein expression, p-NF-κB protein expression, and p-IKB-α protein expression in RA-FLS. Furthermore, following experiment showed that lnc-AL928768.3 positively regulated LTB expression while LTB did not impact on lnc-AL928768.3 expression in RA-FLS. Furthermore, in rescue experiments, LTB overexpression curtailed the effect of lnc-AL928768.3 knock-down on regulating proliferation, invasion, apoptosis and inflammatory cytokine expressions in RA-FLS. Lnc-AL928768.3 promotes proliferation, invasion, and inflammation while inhibits apoptosis of RA-FLS via activating LTB mediated NF-κB signaling.
Similar content being viewed by others
Availability of Data And Materials
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Croia, C., R. Bursi, D. Sutera, et al. 2019. One year in review 2019: Pathogenesis of rheumatoid arthritis. Clinical and Experimental Rheumatology 37: 347–357.
Firestein, G.S., and I.B. McInnes. 2017. Immunopathogenesis of Rheumatoid Arthritis. Immunity 46: 183–196.
Wasserman, A. 2018. Rheumatoid Arthritis: Common Questions About Diagnosis and Management. American Family Physician 97: 455–462.
Zhao, S., E. Mysler, and R.J. Moots. 2018. Etanercept for the treatment of rheumatoid arthritis. Immunotherapy 10: 433–445.
Bluett, J., and A. Barton. 2017. Precision Medicine in Rheumatoid Arthritis. Rheumatic Diseases Clinics of North America 43: 377–387.
Quinn, J.J., and H.Y. Chang. 2016. Unique features of long non-coding RNA biogenesis and function. Nature Reviews Genetics 17: 47–62.
Uszczynska-Ratajczak, B., J. Lagarde, A. Frankish, et al. 2018. Towards a complete map of the human long non-coding RNA transcriptome. Nature Reviews Genetics 19: 535–548.
Peng, W.X., P. Koirala, and Y.Y. Mo. 2017. LncRNA-mediated regulation of cell signaling in cancer. Oncogene 36: 5661–5667.
Ma, P., Y. Li, W. Zhang, et al. 2019. Long Non-coding RNA MALAT1 Inhibits Neuron Apoptosis and Neuroinflammation While Stimulates Neurite Outgrowth and Its Correlation With MiR-125b Mediates PTGS2, CDK5 and FOXQ1 in Alzheimer’s Disease. Current Alzheimer Research 16: 596–612.
Zhang, P., Y. Sun, R. Peng, et al. 2019. Long non-coding RNA Rpph1 promotes inflammation and proliferation of mesangial cells in diabetic nephropathy via an interaction with Gal-3. Cell Death & Disease 10: 526.
Wu, L., J. Xia, D. Li, et al. 2020. Mechanisms of M2 Macrophage-Derived Exosomal Long Non-coding RNA PVT1 in Regulating Th17 Cell Response in Experimental Autoimmune Encephalomyelitisa. Frontiers in Immunology 11: 1934.
Zhang, H.J., Q.F. Wei, S.J. Wang, et al. 2017. LncRNA HOTAIR alleviates rheumatoid arthritis by targeting miR-138 and inactivating NF-kappaB pathway. International Immunopharmacology 50: 283–290.
Hu, X., J. Tang, X. Hu, et al. 2020. Silencing of Long Non-coding RNA HOTTIP Reduces Inflammation in Rheumatoid Arthritis by Demethylation of SFRP1. Mol Ther Nucleic Acids 19: 468–481.
Sun, L., J. Tu, C. Liu, et al. 2020. Analysis of lncRNA expression profiles by sequencing reveals that lnc-AL928768.3 and lnc-AC091493.1 are novel biomarkers for disease risk and activity of rheumatoid arthritis. Inflammopharmacology 28: 437–450.
McCarthy, D.D., L. Summers-Deluca, F. Vu, et al. 2006. The lymphotoxin pathway: Beyond lymph node development. Immunologic Research 35: 41–54.
Spahn, T.W., C. Maaser, L. Eckmann, et al. 2004. The lymphotoxin-beta receptor is critical for control of murine Citrobacter rodentium-induced colitis. Gastroenterology 127: 1463–1473.
Seleznik, G.M., T. Reding, F. Romrig, et al. 2012. Lymphotoxin beta receptor signaling promotes development of autoimmune pancreatitis. Gastroenterology 143: 1361–1374.
O’Rourke, K.P., G. O’Donoghue, C. Adams, et al. 2008. High levels of Lymphotoxin-Beta (LT-Beta) gene expression in rheumatoid arthritis synovium: Clinical and cytokine correlations. Rheumatology International 28: 979–986.
Bustamante, M.F., P.G. Oliveira, R. Garcia-Carbonell, et al. 2018. Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis. Annals of the Rheumatic Diseases 77: 1636–1643.
Lopez-Mejias, R., S. Castaneda, C. Gonzalez-Juanatey, et al. 2016. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers. Autoimmunity Reviews 15: 1013–1030.
Sparks, J.A., S.C. Chang, K.P. Liao, et al. 2016. Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow-Up: Results From the Nurses’ Health Study. Arthritis Care Res (Hoboken) 68: 753–762.
Smolen, J.S., F.C. Breedveld, G.R. Burmester, et al. 2016. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Annals of the Rheumatic Diseases 75: 3–15.
Aletaha, D., M.M. Ward, K.P. Machold, et al. 2005. Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states. Arthritis and Rheumatism 52: 2625–2636.
Felson, D.T., J.S. Smolen, G. Wells, et al. 2011. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Annals of the Rheumatic Diseases 70: 404–413.
Smolen, J.S., F.C. Breedveld, M.H. Schiff, et al. 2003. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 42: 244–257.
Visser, K., and D. van der Heijde. 2009. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: A systematic review of the literature. Annals of the Rheumatic Diseases 68: 1094–1099.
Bullock, J., S.A.A. Rizvi, A.M. Saleh, et al. 2018. Rheumatoid Arthritis: A Brief Overview of the Treatment. Medical Principles and Practice 27: 501–507.
Yan, S., P. Wang, J. Wang, et al. 2019. Long Non-coding RNA HIX003209 Promotes Inflammation by Sponging miR-6089 via TLR4/NF-kappaB Signaling Pathway in Rheumatoid Arthritis. Frontiers in Immunology 10: 2218.
Wang, G., L. Tang, X. Zhang, et al. 2019. LncRNA DILC participates in rheumatoid arthritis by inducing apoptosis of fibroblast-like synoviocytes and down-regulating IL-6. Biosci Rep 39.
Li, G., Y. Liu, F. Meng, et al. 2019. LncRNA MEG3 inhibits rheumatoid arthritis through miR-141 and inactivation of AKT/mTOR signalling pathway. Journal of Cellular and Molecular Medicine 23: 7116–7120.
Gang, X., Y. Sun, F. Li, et al. 2017. Identification of key genes associated with rheumatoid arthritis with bioinformatics approach. Medicine (Baltimore) 96: e7673.
Kim, K.J., J.Y. Kim, I.W. Baek, et al. 2015. Elevated serum levels of syndecan-1 are associated with renal involvement in patients with systemic lupus erythematosus. Journal of Rheumatology 42: 202–209.
Zhu, H., W. Xia, X.B. Mo, et al. 2016. Gene-Based Genome-Wide Association Analysis in European and Asian Populations Identified Novel Genes for Rheumatoid Arthritis. PLoS ONE 11: e0167212.
Ishida, S., S. Yamane, T. Ochi, et al. 2008. LIGHT induces cell proliferation and inflammatory responses of rheumatoid arthritis synovial fibroblasts via lymphotoxin beta receptor. Journal of Rheumatology 35: 960–968.
Hirose, T., Y. Fukuma, A. Takeshita, et al. 2018. The role of lymphotoxin-alpha in rheumatoid arthritis. Inflammation Research 67: 495–501.
Fernandes, M.T., E. Dejardin, and N.R. dos Santos. 2016. Context-dependent roles for lymphotoxin-beta receptor signaling in cancer development. Biochimica et Biophysica Acta 1865: 204–219.
Gubernatorova, E.O., and A.V. Tumanov. 2016. Tumor Necrosis Factor and Lymphotoxin in Regulation of Intestinal Inflammation. Biochemistry (Moscow) 81: 1309–1325.
Braun, A., S. Takemura, A.N. Vallejo, et al. 2004. Lymphotoxin beta-mediated stimulation of synoviocytes in rheumatoid arthritis. Arthritis and Rheumatism 50: 2140–2150.
Sabir, J.S.M., A. El Omri, B. Banaganapalli, et al. 2019. Dissecting the Role of NF-kappab Protein Family and Its Regulators in Rheumatoid Arthritis Using Weighted Gene Co-Expression Network. Frontiers in Genetics 10: 1163.
Zhou, L., L. Li, Y. Wang, et al. 2019. Effects of RANKL on the proliferation and apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis through regulating the NF-kappaB signaling pathway. European Review for Medical and Pharmacological Sciences 23: 9215–9221.
Covarrubias, S., E.K. Robinson, B. Shapleigh, et al. 2017. CRISPR/Cas-based screening of long non-coding RNAs (lncRNAs) in macrophages with an NF-kappaB reporter. Journal of Biological Chemistry 292: 20911–20920.
Acknowledgements
None.
Funding
This study was supported by Natural Science Foundation of Zhejiang Province, China (Grant/Award Number: LY20H100002), Medical Science Research Foundation of Zhejiang Province, China (Grant/Award Number: 2020KY634) and Wenzhou Science and Technology Foundation (Grant/Award Number: Y2020922).
Author information
Authors and Affiliations
Contributions
JC contributed to the conception and design of the study. LS and LH contributed to the data acquisition. PC and YL contributed to the analysis and interpretation of data. JT contributed to drafting/revising of article. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sun, L., Hu, L., Chen, P. et al. Long Non-Coding RNA AL928768.3 Promotes Rheumatoid Arthritis Fibroblast-Like Synoviocytes Proliferation, Invasion and Inflammation, While Inhibits Apoptosis Via Activating Lymphotoxin Beta Mediated NF-κB Signaling Pathway. Inflammation 47, 543–556 (2024). https://doi.org/10.1007/s10753-023-01927-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-023-01927-x